- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Sapio Sciences Launches New Molecule Solution Platform
Sapio chemistry solution unifies small-molecule and large-molecule discovery workflows on a single platform.
Sapio Sciences announced the launch of its Sapio chemistry solution, which unifies small-molecule and large-molecule discovery workflows on a single platform. According to the company, the technology enables scientists to draw insights across all their organization’s discovery experiments.
“Many organizations are still running decades-old electronic laboratory notebooks (ELNs) and other software for capturing chemical synthesis experiments and registering small molecules,” said Kevin Cramer, president, CEO, Sapio Sciences. “Large-molecule and small-molecule discovery have traditionally been managed on disparate systems, creating artificial islands that impede scientific collaboration and decision-making. Sapio is excited to give biopharma organizations the opportunity to consolidate all their chemistry experiments on a modern, unified lab platform.”
Reference
Sapio Sciences Unifies Small- and Large-Molecule Discovery on a Single Platform. Business Wire. October 9, 2023. Accessed October 10, 2023. https://www.businesswire.com/news/home/20231009525095/en/Sapio-Sciences-Unifies-Small--and-Large-Molecule-Discovery-on-a-Single-Platform
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
